Log in to your Inderes Free account to see all free content on this page.
Ependion
142.4
SEK
+3.04 %
Less than 1K followers
EPEN
NASDAQ Stockholm
Hardware Manufacturer
Technology
Overview
Ownership
Investor consensus
+3.04%
+23.18%
+46.65%
+46.65%
+24.48%
+31.85%
+110.03%
+249.88%
+444.97%
Ependion operates in the technology industry and focuses on the development and manufacturing of electronic systems and components. The company's products are used in various sectors, including industry, medical technology and defense. The business is aimed at companies and institutions globally, with the largest presence in Europe and North America. Ependion was founded in 2018 and is headquartered in Stockholm, Sweden.
Read moreMarket cap
4.18B SEK
Turnover
4.49M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
29.4.
2025
Interim report Q1'25
13.5.
2025
General meeting '25
14.5.
2025
Annual dividend
All
Webcasts
Press releases
3rd party
ShowingAll content types
Ependion AB: Nomination Committee Board Proposals for 2025
Carnegie Access: Ependion: Interview - Cautiously optimistic about 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Redeye: Ependion - Welcome recovery in Q4
Carnegie Access: Ependion: Order intake beat gives cause for optimism
Carnegie Access: Ependion: Best order intake since Q2(23) – Q4 first take

Ependion, Audiocast with teleconference, Financial Statement 2024
Ependion AB: Financial Statement 2024: Stronger order intake and results conclude a challenging year
Carnegie Access: Ependion: Expecting demand to have been stable – Q4 preview
Ependion AB: Invitation to presentation of Ependion's Financial Statement 2024
Redeye: Ependion - Weak top-line but resilient margins
Carnegie Commissioned Research: Ependion: Interview - Sluggish demand, but temporary
Carnegie Commissioned Research: Ependion: Weakness is temporary – Q3 initial comment
